go to medicines.ie homepage
  • Home  |  
  • About  |  
  • Links  |  
  • Help
Font Size
Search for:  
select
select
  • SPCs and PILs
  • SPCs Only
  • PILs Only
  Advanced Search
  • What's
    New
      
  • Browse
    Medicines
      
  • Browse
    Active Ingredients
      
  • Browse
    Companies
      
  • Codes
    of Practice
      
  • Adverse
    Reaction Reporting

Bayer Limited

Bayer Limited
The Atrium, Blackthorn Road, Dublin 18,
Telephone: +353 1 2999 313
Fax: +353 1 2061 456
Summary of Product Characteristics last updated on medicines.ie: 17/11/2010
SPC Ciproxin 250mg Film-coated Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 17/11/2010 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 3 - Pharmaceutical form
  • Change to section 6.1 - List of excipients
  • Change to section 6.4 - Special precautions for storage
  • Change to section 6.5 - Nature and contents of container
  • Change to section 10 - Date of revision of the text
Date of revision of text on the SPC:   21-Oct-2010
Legal Category:   Product subject to medical prescription which may not be renewed (A)

Free-text change information supplied by the pharmaceutical company



Superceded Text: June 2010

Updated text: October 2010

2.         QUALITATIVE AND QUANTITATIVE COMPOSITION

 

2.         QUALITATIVE AND QUANTITATIVE COMPOSITION

 

Each tablet contains 291.0mg ciprofloxacin hydrochloride equivalent to 250mg Ciprofloxacin.

 

For a full list of excipients, see Section 6.1.

Each film-coated tablet contains 250 mg ciprofloxacin (as hydrochloride)

 

For a full list of excipients, see section 6.1.

 

3.       PHARMACEUTICAL form

 

3.       PHARMACEUTICAL form

 

Film-coated tablet, round, white to slightly yellow, marked with the 'Bayer Cross' on one side and CIP 250 on the reverse.

Film-coated tablet

 

Round, nearly white to slightly yellowish tablets marked with “CIP score 250” on one side and a Bayer cross on the reverse side.

 

The tablets can be divided into equal halves.

 

6.1     List of excipients

 

6.1     List of excipients

 

Each tablet core contains:

 

microcrystalline cellulose,

maize starch,

crospovidone,

silica, colloidal anhydrous,

magnesium stearate.

 

The tablet film-coat consists of a mixture of:

hypromellose 2910,

Macrogol 4000,

titanium dioxide (E171).

Tablet core :

Cellulose microcrystalline

Crospovidone

Maize starch

Magnesium stearate

Silica colloidal anhydrous

 

Film-coat :

Hypromellose

Macrogol 4000

Titanium dioxide (E171)

 

6.4     Special precautions for storage

 

6.4     Special precautions for storage

 

No special storage precautions are necessary.

This medicinal product does not require any special storage conditions.

 

6.5       Nature and contents of container

 

6.5       Nature and contents of container

 

Blister strips in cardboard outers comprising:

 

a) 250µm, 40g/m2 PVC/PVDC foil with 20µm hard aluminium backing foil.

 

Pack sizes 10, 20, 100 tablets.

 

b) 300µm polypropylene foil with 20µm hard aluminium backing foil with a 3.5g/m2 heat seal polypropylene coating.

 

Pack sizes: 10, 20, 100 tablets.

 

Not all pack sizes may be marketed.

One of the following primary packaging materials is used:

Transparent colourless or white opaque PVC/PVDC/Aluminum blister

Transparent colourless or white opaque PP/Aluminum blister

Aluminum/Aluminum blister

 

Pack sizes of 6, 8, 10, 12, 14, 16, 20, 28, 50, 100, 160 or 500 film-coated tablets

 

Not all pack sizes may be marketed.

 

10.     DATE OF REVISION OF THE TEXT

 

10.     DATE OF REVISION OF THE TEXT

 

June 2010

September 2010

 

Updated on 29/09/2010 and displayed until 17/11/2010
Reasons for adding or updating:
  • New individual SPC (was previously included in combined SPC)
Date of revision of text on the SPC:  
Legal Category:   Product subject to medical prescription which may not be renewed (A)

Free-text change information supplied by the pharmaceutical company

None provided

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Ciprofloxacin hydrochloride

Versions

 
17/11/2010 to Current
29/09/2010 to 17/11/2010
  • Terms & Conditions | 
  • Accessibility | 
  • Privacy Statement | 
  • Contact Us

Registered Address: Franklin House, 140 Pembroke Road, Dublin 4, Ireland
Registered Number: 254776
Tel: (353 1) 6603350 Fax: (353 1) 6686672 Email: info@ipha.ie

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

logo